Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ATP6 pseudogene 30 (MTATP6P30) is a mitochondrial pseudogene that shares sequence similarity with the protein-coding MT-ATP6 gene but does not encode a functional protein. Pseudogenes are typically regarded as non-functional genomic elements arising from duplication or retrotransposition events and are not known to participate in biological processes or be involved in disease or drug mechanisms. MTATP6P30 is annotated due to its sequence similarity rather than any demonstrated physiological or pathological role[7].
None (pseudogenes are not directly targeted by drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ATP6 pseudogene 30 (MTATP6P30).